Enhanced repair of the anterior cruciate ligament by in situ gene transfer: Evaluation in an in vitro model

Arnulf Pascher, Andre F. Steinert, Glyn D. Palmer, Oliver Betz, Jean Noel Gouze, Elvire Gouze, Carmencita Pilapil, Stephen C. Ghivizzani, Christopher H Evans, Martha Meaney Murray

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The inability of the ruptured anterior cruciate ligament (ACL) of the knee joint to heal spontaneously presents numerous clinical problems. Here we describe a novel, gene-based approach to augment ACL healing. It is based upon the migration of cells from the ruptured ends of the ligament into a collagen hydrogel laden with recombinant adenovirus. Cells entering the gel become transduced by the vector, which provides a basis for the local synthesis of gene products that aid repair. Monolayers of bovine ACL cells were readily transduced by first-generation, recombinant adenovirus, and transgene expression remained high after the cells were incorporated into collagen hydrogels. Using an in vitro model of ligament repair, cells migrated from the cut ends of the ACL into the hydrogel and were readily transduced by recombinant adenovirus contained within it. The results of experiments in which GFP was used as the transgene suggest highly efficient transduction of ACL cells in this manner. Moreover, during a 21-day period GFP+ cells were observed more than 6 mm from the severed ligament. This distance is ample for the projected clinical application of this technology. In response to TGF-β1 as the transgene, greater numbers of ACL cells accumulated in the hydrogels, where they deposited larger amounts of type III collagen. These data confirm that it is possible to transduce ACL cells efficiently in situ as they migrate from the ruptured ACL, that transduction does not interfere with the cells' ability to migrate distances necessary for successful repair, and that ACL cells will respond in a suitable manner to the products of the transgenes they express. This permits optimism over a possible clinical use for this technology.

Original languageEnglish (US)
Pages (from-to)327-336
Number of pages10
JournalMolecular Therapy
Volume10
Issue number2
DOIs
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Anterior Cruciate Ligament
Genes
Transgenes
Ligaments
Adenoviridae
Hydrogels
Hydrogel
Collagen
In Vitro Techniques
Technology
Aptitude
Collagen Type III
Knee Joint
Cell Movement
Gels

Keywords

  • Anterior cruciate ligament
  • Collagen hydrogel
  • Gene therapy
  • TGF-β

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Pascher, A., Steinert, A. F., Palmer, G. D., Betz, O., Gouze, J. N., Gouze, E., ... Murray, M. M. (2004). Enhanced repair of the anterior cruciate ligament by in situ gene transfer: Evaluation in an in vitro model. Molecular Therapy, 10(2), 327-336. https://doi.org/10.1016/j.ymthe.2004.03.012

Enhanced repair of the anterior cruciate ligament by in situ gene transfer : Evaluation in an in vitro model. / Pascher, Arnulf; Steinert, Andre F.; Palmer, Glyn D.; Betz, Oliver; Gouze, Jean Noel; Gouze, Elvire; Pilapil, Carmencita; Ghivizzani, Stephen C.; Evans, Christopher H; Murray, Martha Meaney.

In: Molecular Therapy, Vol. 10, No. 2, 08.2004, p. 327-336.

Research output: Contribution to journalArticle

Pascher, A, Steinert, AF, Palmer, GD, Betz, O, Gouze, JN, Gouze, E, Pilapil, C, Ghivizzani, SC, Evans, CH & Murray, MM 2004, 'Enhanced repair of the anterior cruciate ligament by in situ gene transfer: Evaluation in an in vitro model', Molecular Therapy, vol. 10, no. 2, pp. 327-336. https://doi.org/10.1016/j.ymthe.2004.03.012
Pascher, Arnulf ; Steinert, Andre F. ; Palmer, Glyn D. ; Betz, Oliver ; Gouze, Jean Noel ; Gouze, Elvire ; Pilapil, Carmencita ; Ghivizzani, Stephen C. ; Evans, Christopher H ; Murray, Martha Meaney. / Enhanced repair of the anterior cruciate ligament by in situ gene transfer : Evaluation in an in vitro model. In: Molecular Therapy. 2004 ; Vol. 10, No. 2. pp. 327-336.
@article{e1bece5410a54759a52b85379d361c50,
title = "Enhanced repair of the anterior cruciate ligament by in situ gene transfer: Evaluation in an in vitro model",
abstract = "The inability of the ruptured anterior cruciate ligament (ACL) of the knee joint to heal spontaneously presents numerous clinical problems. Here we describe a novel, gene-based approach to augment ACL healing. It is based upon the migration of cells from the ruptured ends of the ligament into a collagen hydrogel laden with recombinant adenovirus. Cells entering the gel become transduced by the vector, which provides a basis for the local synthesis of gene products that aid repair. Monolayers of bovine ACL cells were readily transduced by first-generation, recombinant adenovirus, and transgene expression remained high after the cells were incorporated into collagen hydrogels. Using an in vitro model of ligament repair, cells migrated from the cut ends of the ACL into the hydrogel and were readily transduced by recombinant adenovirus contained within it. The results of experiments in which GFP was used as the transgene suggest highly efficient transduction of ACL cells in this manner. Moreover, during a 21-day period GFP+ cells were observed more than 6 mm from the severed ligament. This distance is ample for the projected clinical application of this technology. In response to TGF-β1 as the transgene, greater numbers of ACL cells accumulated in the hydrogels, where they deposited larger amounts of type III collagen. These data confirm that it is possible to transduce ACL cells efficiently in situ as they migrate from the ruptured ACL, that transduction does not interfere with the cells' ability to migrate distances necessary for successful repair, and that ACL cells will respond in a suitable manner to the products of the transgenes they express. This permits optimism over a possible clinical use for this technology.",
keywords = "Anterior cruciate ligament, Collagen hydrogel, Gene therapy, TGF-β",
author = "Arnulf Pascher and Steinert, {Andre F.} and Palmer, {Glyn D.} and Oliver Betz and Gouze, {Jean Noel} and Elvire Gouze and Carmencita Pilapil and Ghivizzani, {Stephen C.} and Evans, {Christopher H} and Murray, {Martha Meaney}",
year = "2004",
month = "8",
doi = "10.1016/j.ymthe.2004.03.012",
language = "English (US)",
volume = "10",
pages = "327--336",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Enhanced repair of the anterior cruciate ligament by in situ gene transfer

T2 - Evaluation in an in vitro model

AU - Pascher, Arnulf

AU - Steinert, Andre F.

AU - Palmer, Glyn D.

AU - Betz, Oliver

AU - Gouze, Jean Noel

AU - Gouze, Elvire

AU - Pilapil, Carmencita

AU - Ghivizzani, Stephen C.

AU - Evans, Christopher H

AU - Murray, Martha Meaney

PY - 2004/8

Y1 - 2004/8

N2 - The inability of the ruptured anterior cruciate ligament (ACL) of the knee joint to heal spontaneously presents numerous clinical problems. Here we describe a novel, gene-based approach to augment ACL healing. It is based upon the migration of cells from the ruptured ends of the ligament into a collagen hydrogel laden with recombinant adenovirus. Cells entering the gel become transduced by the vector, which provides a basis for the local synthesis of gene products that aid repair. Monolayers of bovine ACL cells were readily transduced by first-generation, recombinant adenovirus, and transgene expression remained high after the cells were incorporated into collagen hydrogels. Using an in vitro model of ligament repair, cells migrated from the cut ends of the ACL into the hydrogel and were readily transduced by recombinant adenovirus contained within it. The results of experiments in which GFP was used as the transgene suggest highly efficient transduction of ACL cells in this manner. Moreover, during a 21-day period GFP+ cells were observed more than 6 mm from the severed ligament. This distance is ample for the projected clinical application of this technology. In response to TGF-β1 as the transgene, greater numbers of ACL cells accumulated in the hydrogels, where they deposited larger amounts of type III collagen. These data confirm that it is possible to transduce ACL cells efficiently in situ as they migrate from the ruptured ACL, that transduction does not interfere with the cells' ability to migrate distances necessary for successful repair, and that ACL cells will respond in a suitable manner to the products of the transgenes they express. This permits optimism over a possible clinical use for this technology.

AB - The inability of the ruptured anterior cruciate ligament (ACL) of the knee joint to heal spontaneously presents numerous clinical problems. Here we describe a novel, gene-based approach to augment ACL healing. It is based upon the migration of cells from the ruptured ends of the ligament into a collagen hydrogel laden with recombinant adenovirus. Cells entering the gel become transduced by the vector, which provides a basis for the local synthesis of gene products that aid repair. Monolayers of bovine ACL cells were readily transduced by first-generation, recombinant adenovirus, and transgene expression remained high after the cells were incorporated into collagen hydrogels. Using an in vitro model of ligament repair, cells migrated from the cut ends of the ACL into the hydrogel and were readily transduced by recombinant adenovirus contained within it. The results of experiments in which GFP was used as the transgene suggest highly efficient transduction of ACL cells in this manner. Moreover, during a 21-day period GFP+ cells were observed more than 6 mm from the severed ligament. This distance is ample for the projected clinical application of this technology. In response to TGF-β1 as the transgene, greater numbers of ACL cells accumulated in the hydrogels, where they deposited larger amounts of type III collagen. These data confirm that it is possible to transduce ACL cells efficiently in situ as they migrate from the ruptured ACL, that transduction does not interfere with the cells' ability to migrate distances necessary for successful repair, and that ACL cells will respond in a suitable manner to the products of the transgenes they express. This permits optimism over a possible clinical use for this technology.

KW - Anterior cruciate ligament

KW - Collagen hydrogel

KW - Gene therapy

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=4344595112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344595112&partnerID=8YFLogxK

U2 - 10.1016/j.ymthe.2004.03.012

DO - 10.1016/j.ymthe.2004.03.012

M3 - Article

C2 - 15294179

AN - SCOPUS:4344595112

VL - 10

SP - 327

EP - 336

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 2

ER -